In August 2023, Jaclyn Bjorklund filed a lawsuit against Novo Nordisk, asserting that her use of Ozempic resulted in severe vomiting that led to the loss of her teeth. Her symptoms necessitated multiple hospitalizations and complications have required her to take additional medication for excessive vomiting. As Bjorklund switched from Ozempic to Mounjaro, this case also involves Eli Lilly’s Mounjaro (tirzepatide) for similar adverse effects.
Bjorklund’s lawsuit contends that both pharmaceutical giants failed to adequately warn patients about the severe gastrointestinal risks linked to their medications. This lawsuit is among the first to spotlight the significant health complications associated with GLP-1 receptor agonists, paving the way for future litigation.
In December 2023, a significant lawsuit was filed in Louisiana federal court, alleging that Novo Nordisk’s Ozempic caused severe vomiting and tooth loss. Novo Nordisk moved to dismiss the case, arguing insufficient grounds for the claims. However, the court predominantly rejected their motion, allowing the majority of the claims to proceed. This case exemplifies the growing legal challenges Novo Nordisk faces over the alleged severe side effects of Ozempic, emphasizing the judiciary’s readiness to scrutinize the company’s defense strategies.
In January 2024, numerous lawsuits were consolidated into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, presided over by Judge Gene E.K. Pratter. This consolidation aimed to streamline the legal proceedings related to Ozempic and other GLP-1 receptor agonists, including Wegovy and Trulicity.
The U.S. Judicial Panel on Multidistrict Litigation officially established the MDL in February 2024, combining at least 55 lawsuits into this centralized process. This move is expected to efficiently handle the increasing number of cases and address the severe gastrointestinal side effects allegedly caused by these medications.
Novo Nordisk did not provide adequate warning to inform patients of the severe gastrointestinal risks associated with Ozempic, resulting in significant health complications for many users.
Were you prescribed Ozempic and experienced severe side effects like gastroparesis or vomiting? You may be entitled to significant compensation.
Get in touch with us today, and let us help you pursue the
Ozempic lawsuit compensation you deserve.
